Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Prestige Consumer Healthcare's operating cash flow for the twelve months ending Jun 30, 2026 was $249.40M, down 9.6% year over year. For fiscal 2026 it was $257.63M, up 2.4% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is $259.92M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $257.63M | +2.4% |
| FY2025 | Mar 31, 2025 | $251.52M | +1.0% |
| FY2024 | Mar 31, 2024 | $248.93M | +8.4% |
| FY2023 | Mar 31, 2023 | $229.72M | -11.6% |
| FY2022 | Mar 31, 2022 | $259.92M | +10.3% |
| FY2021 | Mar 31, 2021 | $235.61M | +8.5% |
| FY2020 | Mar 31, 2020 | $217.12M | +14.7% |
| FY2019 | Mar 31, 2019 | $189.28M | -9.9% |
| FY2018 | Mar 31, 2018 | $210.11M | +41.3% |
| FY2017 | Mar 31, 2017 | $148.67M | -15.7% |
| FY2016 | Mar 31, 2016 | $176.31M | +12.8% |
| FY2015 | Mar 31, 2015 | $156.26M | +40.0% |
| FY2014 | Mar 31, 2014 | $111.58M | -18.9% |
| FY2013 | Mar 31, 2013 | $137.61M | +104.0% |
| FY2012 | Mar 31, 2012 | $67.45M | -22.2% |
| FY2011 | Mar 31, 2011 | $86.67M | +45.8% |
| FY2010 | Mar 31, 2010 | $59.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $70.79M | -10.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $42.84M | -30.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $78.29M | +20.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $57.49M | -17.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $79.01M | +44.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $61.85M | -7.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $65.09M | -8.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $69.80M | +11.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $54.78M | +13.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $66.91M | +13.4% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $71.47M | +30.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $62.46M | +8.6% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $48.09M | -17.4% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $58.99M | -6.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $54.94M | -17.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $57.54M | -6.0% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $58.25M | -16.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $63.13M | +6.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $66.30M | +34.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $61.19M | +17.4% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $69.31M | -7.8% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $59.09M | +5.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $49.23M | -15.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $52.14M | +3.8% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $75.15M | +42.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $56.13M | +10.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $58.00M | +33.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $50.22M | +27.9% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $52.78M | -5.5% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $50.85M | -6.6% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $43.33M | -8.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $39.26M | -27.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $55.85M | +3.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $54.44M | +623.5% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $47.13M | +17.6% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $54.42M | +9.3% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $54.12M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $7.52M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $40.07M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $49.78M | – |
See a number that looks wrong?